Evidence map›Paper›PMID 26984409›Full record

ArticleThe Journal of biological chemistry2016

p75 Neurotrophin Receptor Signaling Activates Sterol Regulatory Element-binding Protein-2 in Hepatocyte Cells via p38 Mitogen-activated Protein Kinase and Caspase-3.

Dan Duc Pham, Hai Thi Do, Céline Bruelle, Jyrki P Kukkonen, Ove Eriksson, Isabel Mogollón, Laura T Korhonen, Urmas Arumäe, Dan Lindholm

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.3field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 21 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Metabolic Control of Sensory Neuron Survival by the p75 Neurotrophin Receptor in Schwann Cells.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2021
    Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Dan Duc PhamFrom the Medicum, Department of Biochemistry and Developmental Biology, Medical Faculty, University of Helsinki, P. O. Box 63, Helsinki FIN-00014, Finland, the Minerva Foundation Institute for Medical Research, Biomedicum-2, Tukholmankatu 8, FIN-00290 Helsinki, Finland.
Hai Thi DoFrom the Medicum, Department of Biochemistry and Developmental Biology, Medical Faculty, University of Helsinki, P. O. Box 63, Helsinki FIN-00014, Finland, the Minerva Foundation Institute for Medical Research, Biomedicum-2, Tukholmankatu 8, FIN-00290 Helsinki, Finland.
Céline BruelleFrom the Medicum, Department of Biochemistry and Developmental Biology, Medical Faculty, University of Helsinki, P. O. Box 63, Helsinki FIN-00014, Finland, the Minerva Foundation Institute for Medical Research, Biomedicum-2, Tukholmankatu 8, FIN-00290 Helsinki, Finland.
Jyrki P KukkonenBiochemistry and Cell Biology, Department of Veterinary Biosciences, P. O. Box 66, University of Helsinki, Helsinki FIN-00014, Finland.
Ove ErikssonFrom the Medicum, Department of Biochemistry and Developmental Biology, Medical Faculty, University of Helsinki, P. O. Box 63, Helsinki FIN-00014, Finland.
Isabel MogollónFrom the Medicum, Department of Biochemistry and Developmental Biology, Medical Faculty, University of Helsinki, P. O. Box 63, Helsinki FIN-00014, Finland, the Minerva Foundation Institute for Medical Research, Biomedicum-2, Tukholmankatu 8, FIN-00290 Helsinki, Finland.
Laura T KorhonenFrom the Medicum, Department of Biochemistry and Developmental Biology, Medical Faculty, University of Helsinki, P. O. Box 63, Helsinki FIN-00014, Finland, the Minerva Foundation Institute for Medical Research, Biomedicum-2, Tukholmankatu 8, FIN-00290 Helsinki, Finland.
Urmas Arumäethe Research Program in Developmental Biology, Institute of Biotechnology, University of Helsinki, P. O. Box 65, Helsinki FIN-00014, Finland, and the Department of Gene Technology, Tallinn University of Technology, Akadeemia tee 15, Tallinn 12618, Estonia.
Dan LindholmFrom the Medicum, Department of Biochemistry and Developmental Biology, Medical Faculty, University of Helsinki, P. O. Box 63, Helsinki FIN-00014, Finland, the Minerva Foundation Institute for Medical Research, Biomedicum-2, Tukholmankatu 8, FIN-00290 Helsinki, Finland, dan.lindholm@helsinki.fi.
University of Helsinki · FIMinerva Foundation · FITallinn University of Technology · EE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nerve growth factor (NGF) influences the survival and differentiation of a specific population of neurons during development, but its role in non-neuronal cells has been less studied. We observed here that NGF and its pro-form, pro-NGF, are elevated in fatty livers from leptin-deficient mice compared with controls, concomitant with an increase in low density lipoprotein receptors (LDLRs). Stimulation of mouse primary hepatocytes with NGF or pro-NGF increased LDLR expression through the p75 neurotrophin receptor (p75NTR). Studies using Huh7 human hepatocyte cells showed that the neurotrophins activate the sterol regulatory element-binding protein-2 (SREBP2) that regulates genes involved in lipid metabolism. The mechanisms for this were related to stimulation of p38 mitogen-activated protein kinase (p38 MAPK) and activation of caspase-3 and SREBP2 cleavage following NGF and pro-NGF stimulations. Cell fractionation experiments showed that caspase-3 activity was increased particularly in the membrane fraction that harbors SREBP2 and caspase-2. Experiments showed further that caspase-2 interacts with pro-caspase-3 and that p38 MAPK reduced this interaction and caused caspase-3 activation. Because of the increased caspase-3 activity, the cells did not undergo cell death following p75NTR stimulation, possibly due to concomitant activation of nuclear factor-κB (NF-κB) pathway by the neurotrophins. These results identify a novel signaling pathway triggered by ligand-activated p75NTR that via p38 MAPK and caspase-3 mediate the activation of SREBP2. This pathway may regulate LDLRs and lipid uptake particularly after injury or during tissue inflammation accompanied by an increased production of growth factors, including NGF and pro-NGF.

Indexed as

AnimalsCaspase 3Cell LineFatty LiverHepatocytesHumansMiceMice, Inbred C57BLMice, KnockoutMice, ObeseNerve Growth FactorNerve Tissue Proteinsp38 Mitogen-Activated Protein KinasesReceptors, LDLReceptors, Nerve Growth FactorSignal TransductionCASP3 protein, humanCasp3 protein, mouseCaspase 3Nerve Growth FactorNerve Tissue ProteinsNGFR protein, humanNgfr protein, mousep38 Mitogen-Activated Protein KinasesReceptors, LDLReceptors, Nerve Growth FactorSREBF2 protein, humanSrebf2 protein, mouseSterol Regulatory Element Binding Protein 2caspasehepatocyteLDLRneurotrophinNGFp38 MAPKp75 neurotrophin receptorpro-NGFSREBP2

Identifiers

PMID26984409
PMCPMC4865921
OpenAlexW2315305467

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.